WO2009046819A2 - Procédé de réduction de symptômes cutanés de vieillissement - Google Patents
Procédé de réduction de symptômes cutanés de vieillissement Download PDFInfo
- Publication number
- WO2009046819A2 WO2009046819A2 PCT/EP2008/007782 EP2008007782W WO2009046819A2 WO 2009046819 A2 WO2009046819 A2 WO 2009046819A2 EP 2008007782 W EP2008007782 W EP 2008007782W WO 2009046819 A2 WO2009046819 A2 WO 2009046819A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- applicator
- skin
- coupling medium
- shock waves
- vitamin
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- 230000032683 aging Effects 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 230000009467 reduction Effects 0.000 claims abstract description 7
- 230000035939 shock Effects 0.000 claims description 30
- 230000008878 coupling Effects 0.000 claims description 20
- 238000010168 coupling process Methods 0.000 claims description 20
- 238000005859 coupling reaction Methods 0.000 claims description 20
- 239000002537 cosmetic Substances 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 6
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- MIJPAVRNWPDMOR-UHFFFAOYSA-N [2-(1,2-dihydroxyethyl)-3-hydroxy-5-oxo-2h-furan-4-yl] dihydrogen phosphate Chemical class OCC(O)C1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-UHFFFAOYSA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 229960001948 caffeine Drugs 0.000 claims description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 3
- 229960004203 carnitine Drugs 0.000 claims description 3
- 229960003624 creatine Drugs 0.000 claims description 3
- 239000006046 creatine Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims 1
- 230000019612 pigmentation Effects 0.000 claims 1
- 208000035484 Cellulite Diseases 0.000 abstract description 9
- 206010049752 Peau d'orange Diseases 0.000 abstract description 9
- 230000036232 cellulite Effects 0.000 abstract description 9
- 230000006872 improvement Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 28
- 230000000694 effects Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 8
- 206010040954 Skin wrinkling Diseases 0.000 description 6
- 210000002808 connective tissue Anatomy 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000000913 Kidney Calculi Diseases 0.000 description 3
- 206010029148 Nephrolithiasis Diseases 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 208000032544 Cicatrix Diseases 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000013532 laser treatment Methods 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009213 extracorporeal shockwave therapy Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008427 tissue turnover Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037331 wrinkle reduction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/008—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms using shock waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
- A61H2201/105—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy with means for delivering media, e.g. drugs or cosmetics
Definitions
- the invention relates to a method for the selective reduction of aging skin phenomena (aging skin phenomena), a suitable apparatus and preparations for this method and the use of those for the selective improvement of aging skin phenomena, in particular cellulite and skin flaccidity.
- Shock waves have different characteristics than ultrasound.
- ultrasound there is a high-frequency tissue turnover in the range of a few megahertz, which leads to warming, tissue rupture and cavitation at high amplitudes.
- the effect of shock waves is due to a forward force action (in the direction of propagation of the shock waves) with momentum transfer to the interface.
- Focused and Unfocused Pressure and Shockwaves Differences and Similarities by J. Fehre, W. Krauss, A. Lutz, R. Reidmajer, A. T ⁇ th-Kischkat, F. Ueberle, O. Wess - German-Speaking International Society for Extracorporeal Shockwave Therapy eV (DIGEST)
- the transition from airborne sound to solids or liquids only takes place when the sound waves are emitted in the immediate vicinity or when a coupling medium has adapted acoustic properties and a certain thickness in between. Since these force effects occur essentially at interfaces with a jump of the acoustic resistance, but hardly in homogeneous medium (tissue, water), the shock wave is the ideal means to produce effects in the depth of the tissue, without affecting the upstream tissue , But also less pronounced interfaces within soft tissue structures experience a low force effect by shock waves. Discussed are the mechanical destruction of cells, membranes and z. B. bone trabeculae, but also the cell stimulation by reversible deformation of the cell membrane.
- Shock waves can also be used as an effective massage stimulus, given a suitable choice of sound field and intensity.
- a shockwave therapy usually an increased blood circulation and an intensified metabolism are observed, which can be held responsible for the onset of healing.
- shock wave therapy to human or animal life forms are designed so that the shock waves are focused specifically on areas within the body. Thereby it is possible e.g. To smash kidney stones. An energy input in the area of the upper skin layers is strictly avoided in order to obtain a high energy efficiency at the focal point.
- Every person shows a personal skin picture.
- the surface texture of the skin is unique, thereby it is possible to identify people based on their fingerprints.
- the cellulite is a hormone-related dimming of the skin, which can occur mainly in the thighs, upper arms, hips and buttocks. It occurs predominantly in women, as men have a different connective tissue structure. Cellulite can occur at a very young age and is not associated with weight alone but also affects women with normal and low BMI. In the subcutis, there are more and more fat cells. Collagen fibers, which provide there tear resistance, store in the woman parallel next to each other, while they are net-like interwoven man. This allows growing fat cells to squeeze through between the collagen fibers and become visible on the surface. This creates the typical structure on the affected areas.
- the object of the invention is therefore to provide a method and a device which can be used for the method in order to get over the aging skin phenomena by targeted energy input in the form of shock waves and to reduce these.
- Aging skin phenomena also include wrinkling of the skin with increasing age and elasticity of the skin.
- the method is also suitable for tightening the skin, for reducing cellulite and for reducing the depth of skin fold.
- the consumer is given a permanent, visually more uniform appearance of his skin, without the scars remaining.
- Under protection is therefore a method for reducing the reduction of aging skin phenomena, characterized in that in a first step, a coupling medium is applied to the skin or on the applicator, in a second step, the applicator is placed on the skin and in a third step the skin is stimulated by shock waves emitted by the applicator.
- Applicators according to the invention have a shock wave generator, wherein the shock waves can escape from at least part of the outer surface of the applicator and this part of the outer surface (attachment surface) of the applicator is designed so that it can be safely passed over the skin.
- Coupling media in the context of the invention are fluid preparations that support the initiation of emerging from the applicator shock waves in the skin.
- shock waves lead to a penetration enhancement of the active ingredients, with some agents support wrinkle reduction, tightening of the skin and the reduction of cellulite.
- Coupling media in the context of the invention are fluid preparations which improve or only enable energy transfer from the applicator to the skin surface.
- the use of coupling media is already prior art, wherein known coupling media are usually aqueous gels without cosmetic claim.
- hydrodispersions or gels enriched with cosmetic adjuvants also provides e.g. Benefits due to a cooling effect.
- preparations enriched with caffeine, carnitine, creatine, vitamin C and its derivatives are suitable.
- the coupling medium is an emulsion, in particular W / O or O / W emulsion.
- Hydroemulsions are also among the beneficial coupling media.
- the coupling media are cosmetic preparations which contain at least one mono- or dihydric alcohol, in particular glycols or glycerol
- devices have a shock wave generator, the pressure pulse generation is carried out by converting electrical energy into acoustic energy.
- the generation of the shock waves by piezoelectronic pressure pulse generation, electromagnetic pressure pulse generation, in particular with a cylindrical coil or flat coil. Reflectors or lenses can be used to focus the shockwaves.
- the applicators according to the invention preferably have a circular or oval attachment surface, with which the device is placed on the skin area to be stimulated.
- the attachment surface has a size of 5 to 1000 mm 2 and / or 2.5 to 40 mm in diameter, in particular 10 to 500 mm 2 surface and / or 3.5 to 26 mm in diameter.
- the required treatment depth that is to say the effective range of the shock waves, can be set between 10 ⁇ m and 6000 ⁇ m as a function of the treatment objective.
- shock waves For skin tightening it is necessary that the dermis and subcutis are stimulated by shock waves, as this is the reconstruction of connective tissue and connective tissue septa, analogous to a wound healing, initialized. It is particularly advantageous if the shock waves unfold their effect at a depth of approximately 50 to 5000 ⁇ m.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
L'invention concerne : un procédé de réduction sélective de phénomènes cutanés dus au vieillissement (symptômes cutanés de vieillissement) ; un dispositif et des préparations convenant pour ce procédé ; et leur utilisation pour l'amélioration sélective de phénomènes cutanés dus au vieillissement, en particulier de la cellulite et du relâchement de la peau.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007000799.1 | 2007-10-01 | ||
| DE200710000799 DE102007000799A1 (de) | 2007-10-01 | 2007-10-01 | Verfahren zur Reduktion von Altershauterscheinungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2009046819A2 true WO2009046819A2 (fr) | 2009-04-16 |
| WO2009046819A3 WO2009046819A3 (fr) | 2009-08-06 |
Family
ID=40383960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2008/007782 WO2009046819A2 (fr) | 2007-10-01 | 2008-09-18 | Procédé de réduction de symptômes cutanés de vieillissement |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE102007000799A1 (fr) |
| WO (1) | WO2009046819A2 (fr) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2619007A1 (fr) * | 1987-08-07 | 1989-02-10 | Dermatologiques Et | Preparations cosmetiques a action lipolytique |
| US5523090A (en) * | 1995-02-24 | 1996-06-04 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Skin treatment composition |
| DE19721218A1 (de) * | 1997-05-21 | 1998-11-26 | Dornier Medizintechnik | Verwendung einer Impulsschallquelle |
| EP1062933A2 (fr) * | 1999-06-22 | 2000-12-27 | Richard Wolf GmbH | Appareil, en particulier pour thérapie, pour le traitement d'objets par sons focalisés |
| WO2003011241A1 (fr) * | 2001-07-25 | 2003-02-13 | Beiersdorf Ag | Utilisation de creatinine et/ou de derives de la creatinine dans des preparations cosmetiques ou dermatologiques |
| US20040067890A1 (en) * | 2002-10-04 | 2004-04-08 | Gupta Shyam K. | Ascorbic acid salts of organic bases with enhanced bioavailability for synergictic anti-aging and skin protective cosmetic compositions |
| US20060100550A1 (en) * | 2004-10-22 | 2006-05-11 | Reiner Schultheiss | Pressure pulse/shock wave therapy methods and an apparatus for conducting the therapeutic methods |
| US20060134147A1 (en) * | 2004-12-21 | 2006-06-22 | Avon Products, Inc. | Cosmetic compositions having carnitine creatinate and methods for using |
| WO2007106501A2 (fr) * | 2006-03-13 | 2007-09-20 | The Procter & Gamble Company | Application combinee de composition locale et d'energie pour reguler la condition de peau mammalienne |
| WO2008145260A2 (fr) * | 2007-05-31 | 2008-12-04 | Storz Medical Ag | Appareil médical pour traiter le corps d'un être humain ou d'un animal avec des ondes de pression ou des ondes de choc mécaniques |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10062747C2 (de) * | 2000-12-15 | 2003-04-10 | Dornier Medtech Holding Int Gmbh | Koppelmittel zum schmerzreduzierten Einleiten von Schallwellen in den menschlichen Körper |
| DE10237939A1 (de) * | 2002-08-14 | 2004-04-01 | Rudolf Weyergans | Verfahren und Vorrichtung zur Verbesserung der körperlichen Erscheinung |
-
2007
- 2007-10-01 DE DE200710000799 patent/DE102007000799A1/de not_active Withdrawn
-
2008
- 2008-09-18 WO PCT/EP2008/007782 patent/WO2009046819A2/fr active Application Filing
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2619007A1 (fr) * | 1987-08-07 | 1989-02-10 | Dermatologiques Et | Preparations cosmetiques a action lipolytique |
| US5523090A (en) * | 1995-02-24 | 1996-06-04 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Skin treatment composition |
| DE19721218A1 (de) * | 1997-05-21 | 1998-11-26 | Dornier Medizintechnik | Verwendung einer Impulsschallquelle |
| EP1062933A2 (fr) * | 1999-06-22 | 2000-12-27 | Richard Wolf GmbH | Appareil, en particulier pour thérapie, pour le traitement d'objets par sons focalisés |
| WO2003011241A1 (fr) * | 2001-07-25 | 2003-02-13 | Beiersdorf Ag | Utilisation de creatinine et/ou de derives de la creatinine dans des preparations cosmetiques ou dermatologiques |
| US20040067890A1 (en) * | 2002-10-04 | 2004-04-08 | Gupta Shyam K. | Ascorbic acid salts of organic bases with enhanced bioavailability for synergictic anti-aging and skin protective cosmetic compositions |
| US20060100550A1 (en) * | 2004-10-22 | 2006-05-11 | Reiner Schultheiss | Pressure pulse/shock wave therapy methods and an apparatus for conducting the therapeutic methods |
| US20060134147A1 (en) * | 2004-12-21 | 2006-06-22 | Avon Products, Inc. | Cosmetic compositions having carnitine creatinate and methods for using |
| WO2007106501A2 (fr) * | 2006-03-13 | 2007-09-20 | The Procter & Gamble Company | Application combinee de composition locale et d'energie pour reguler la condition de peau mammalienne |
| WO2008145260A2 (fr) * | 2007-05-31 | 2008-12-04 | Storz Medical Ag | Appareil médical pour traiter le corps d'un être humain ou d'un animal avec des ondes de pression ou des ondes de choc mécaniques |
Non-Patent Citations (1)
| Title |
|---|
| DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 28. November 2005 (2005-11-28), SIEMS, WERNER ET AL: "Anti-fibrosclerotic effects of shock wave therapy in lipedema and cellulite" XP002520985 gefunden im STN Database accession no. 2005:1250512 & BIOFACTORS , 24(1-4), 275-282 CODEN: BIFAEU; ISSN: 0951-6433, 2005, XP009114288 * |
Also Published As
| Publication number | Publication date |
|---|---|
| DE102007000799A1 (de) | 2009-04-02 |
| WO2009046819A3 (fr) | 2009-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Haupt et al. | Effect of shock waves on the healing of partial-thickness wounds in piglets | |
| DE4315282C2 (de) | Verwendung einer akustischen Druckimpulsquelle | |
| DE112008003564T5 (de) | Kombinationstherapie | |
| DE102006012204A1 (de) | Vorrichtung zur Erzeugung elektrischer Entladung | |
| DE20221025U1 (de) | Physiotherapie-Gerät | |
| EP1002510B1 (fr) | Procédé de traitment de cellulite pour l'amélioration de l'apparence physique | |
| EP2404641A2 (fr) | Formule cosmétique pour la réduction de l'apparence extérieure de la cellulite ou de la peau d'orange | |
| WO2009046819A2 (fr) | Procédé de réduction de symptômes cutanés de vieillissement | |
| DE102016122689A1 (de) | Vorrichtung zur Beeinflussung biologischer Abläufe in einem lebenden Gewebe | |
| EP2347407B1 (fr) | Générateur d'ondes d'impulsions | |
| DE1239089B (de) | Verfahren zur Erhoehung der Absorptionsfaehigkeit von Kollagenerzeugnissen im lebenden Koerper | |
| DE102007000800A1 (de) | Vorrichtung und Verfahren zur Reduktion der Hautpigmentierung | |
| DE10137466A1 (de) | Kosmetische Verfahren zur Aknebehandlung, Narbenbehandlung, Hautwiederherstellung bei Pigmentverschiebungen, bei Couperose und bei Schwangerschaftsstreifen, zur Feuchtigkeitseinlagerung und Porenverkleinerung sowie Stoffwechselwiederherstellung mit Körpergewichtsreduzierung | |
| WO2021144080A1 (fr) | Procédé d'incorporation de substances actives dans la peau | |
| EP0281647B1 (fr) | Composés organiques pour le développement des seins | |
| DE102016111727A1 (de) | Vorrichtung zur Behandlung von Zellen mit Hilfe mechanischer Impulse sowie Verfahren zur Steuerung der Vorrichtung | |
| Kim et al. | Therapeutic Effects of Multimodal Biophysical Stimulation on Muscle Atrophy in a Mouse Model | |
| AT510790B1 (de) | Verfahren zur kosmetischen behandlung | |
| DE2318576A1 (de) | Vorrichtung zur beeinflussung des knochenwachstums | |
| WO2003037219A2 (fr) | Utilisation de produits a base de chitosan | |
| DE102019131115A1 (de) | Vorrichtung zur Erzeugung einer lokalen Hyperthermie | |
| DE102013012380A1 (de) | Zubereitung für eine Hautbehandlung | |
| DE8714883U1 (de) | Mobile und stationäre Bade und Therapieeinheit zur Behandlung von Krankheiten im Fuß, Arm und Genitalbereich sowie zur Ganzkörperbehandlung | |
| DE202018002313U1 (de) | Vorrichtung für die kosmetische Ultraschallbehandlung | |
| DE69724840T2 (de) | Nicht-chirurgisches verfahren zur brustvergrösserung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08802306 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 08802306 Country of ref document: EP Kind code of ref document: A2 |